| Literature DB >> 17316448 |
James Dahlgren1, Harpreet Takhar, Pamela Anderson-Mahoney, Jenny Kotlerman, Jim Tarr, Raphael Warshaw.
Abstract
BACKGROUND: This is a community comparison study that examines persons living in a subdivision exposed to petroleum products and mercury.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17316448 PMCID: PMC1821321 DOI: 10.1186/1476-069X-6-8
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Figure 1American College of Rheumatology – The "Eleven Criteria" for diagnosis of SLE.
Figure 2Photograph of Oil Field in Relation to Residents Homes.
Figure 3Close up Photograph of Tank Battery in Relation to one of the two exposed Streets.
Demographic frequencies in Hobbs* and in a control community**
| 18–34 | 35 | 37.63 | 37 | 28.68 | 0.85 |
| 35–49 | 35 | 37.63 | 62 | 48.06 | |
| 50–64 | 19 | 20.43 | 28 | 21.71 | |
| 65+ | 4 | 4.30 | 2 | 1.55 | |
| Total | 93 | 129 | |||
| Hispanic | 44 | 48.89 | 5 | 3.88 | <0.0001 |
| White | 29 | 32.22 | 121 | 93.80 | |
| African American | 12 | 13.33 | 0 | 0 | |
| Others | 5 | 5.55 | 3 | 2.33 | |
| Male | 34 | 37.36 | 61 | 47.29 | 0.21 |
| Female | 57 | 62.64 | 68 | 52.71 | |
| Yes | 35 | 38.89 | 52 | 40.31 | 0.83 |
| No | 55 | 61.11 | 77 | 59.69 | |
| Less than 9th grade | 6 | 6.45 | 0 | 0 | <0.0001 |
| 9 – 11th grade | 22 | 23.66 | 13 | 10.08 | |
| 12th/Vocational/Some College | 57 | 61.29 | 86 | 66.67 | |
| College Graduate | 8 | 8.60 | 30 | 23.26 | |
*a residential population exposed to petroleum products and other environmental contaminants
**no known exposures.
Results for pristane and phytane house-dust sampling for Hobbs, Hobbs-Control, and Control Community.
| Sample Group/Chemical | Pristane* | Phytane* | ||||||
| Avg | SD | Max | Min | Avg | SD | Max | Min | |
| Hobbs (n = 19) | 480.831 | 784.216 | 2441.230 | 13.770 | 262.522 | 542.694 | 2464.530 | 18.750 |
| Hobbs-Control** (n = 3) | 42.437 | 25.868 | 66.290 | 14.940 | 155.277 | 153.763 | 324.320 | 23.730 |
| Tehachapi (n = 9) | 99.029 | 116.491 | 349.310 | 17.940 | 223.969 | 138.587 | 557.440 | 85.220 |
* results in ppm
** Samples collected 2 miles outside of the Westgate Subdivision
AVG – Average
SD – Standard Deviation
Max – Maximum
Min – Minimum
Air monitoring data for pristane, phytane and PAHs taken at baseline and during trenching operations*
| Phytane | 6.10 | 145 | 37.7 | 7.85 | 83.9 | 43.1 |
| Pristane | 4.43 | 182 | 50.5 | 8.21 | 110 | 41.9 |
| Total PAH | 57.0 | 655 | 178 | 89.4 | 769 | 224 |
*Sampling conducted by Oil Company
Results for ambient air mercury sampling for Hobbs, Hobbs-Control, and Control Community.
| Sampling Group | Address | MULTIPLE SAMPLES AT EACH RESIDENCE* | Average | ||||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |||
| Hobbs | Point 1 | 19 | 18 | 21 | 19 | 21 | 19.6 | ||||||||||
| Point 2 | 17 | 18 | 18 | 18 | 20 | 19 | 19 | 18 | 18.38 | ||||||||
| Point 3 | 7 | 8 | 8 | 10 | 17 | 17 | 15 | 16 | 16 | 12.67 | |||||||
| Point 4 | 46 | 73 | 79 | 82 | 68 | 94 | 97 | 157 | 171 | 67 | 103 | 96 | 72.3 | 90 | 19 | 87.64 | |
| Point 5 | 11 | 15 | 32 | 17 | 34 | 23 | 24 | 28 | 27 | 28 | 20 | 23.55 | |||||
| Point 6 | 11 | 9 | 10 | 9 | 12 | 12 | 11 | 14 | 10 | 10.89 | |||||||
| Point 7 | 13 | 14 | 13 | 13 | 15 | 13 | 14 | 13.57 | |||||||||
| Point 8 | 32 | 24 | 33 | 27 | 30 | 35 | 30 | 32 | 35 | 30.89 | |||||||
| Point 9 | 19 | 15 | 14 | 12 | 9 | 15 | 14 | 2 | 12.5 | ||||||||
| Point 10 | 14 | 13 | 13 | 14 | 10 | 12 | 11 | 12.43 | |||||||||
| Hobbs Control** | Point 11 | 7 | 5 | 7 | 6 | 9 | 9 | 7 | 7.14 | ||||||||
| Point 12 | 4 | 0 | 0 | 0 | 0 | 0 | 0.67 | ||||||||||
| Control | Point 13 | 15 | 17.5 | 15 | 19 | 19 | 21 | 17.75 | |||||||||
| Point 14 | 2 | 5 | 6 | 6 | 7 | 5.2 | |||||||||||
| Point 15 | 16 | 15 | 16 | 8 | 13 | 28 | 31 | 30 | 29 | 29 | 32 | 22.45 | |||||
| Point 16 | 7 | 9 | 9 | 12 | 9.25 | ||||||||||||
| Point 17 | 6 | 7 | 7 | 8 | 7 | ||||||||||||
| Point 18 | 18 | 18 | 18 | 12 | 16.5 | ||||||||||||
| Point 19 | 9 | 7 | 6 | 1 | 7 | 5 | 5.83 | ||||||||||
| Point 20 | 4 | 5 | 6 | 3 | 2 | 4 | 9 | 4.71 | |||||||||
| Point 21 | 10 | 11 | 8 | 16 | 12 | 6 | 10.5 | ||||||||||
| Point 22 | 5 | 6 | 5.5 | ||||||||||||||
* 30-second averages, results in nanograms per cubic meter
**Samples collected 2 miles outside of the Westgate Subdivision
Summary Results for ambient air mercury sampling for Hobbs, Hobbs-Control, and Control Community.
| Sample Group/Chemical | Mercury* | |||
| Avg | SD | Max | Min | |
| Hobbs | 24.21 | 31.34 | 171.00 | 2.00 |
| Hobbs-Control** | 3.90 | 3.67 | 9.00 | 0.00 |
| Tehachapi | 10.47 | 8.08 | 32.00 | 1.00 |
* 30-second averages, results in nanograms per cubic meter
**Samples collected 2 miles outside of the Westgate Subdivision
AVG – Average
SD – Standard Deviation
Ordinary least squares regression analysis comparing blood results between exposed and unexposed, controlling for age.
| Number | Mean (SD) | Number | Mean (SD) | Parameter Estimate | P-value | |
| % CD 19 (B-cell) | 43 | 18.07(6.11) | 47 | 14.02(4.68) | 3.98 | 0.0006 |
| % Natural Killer Cells1 | 43 | 10.77(5.65) | 47 | 14.26(7.33) | -3.41 | 0.01 |
| Total bilirubin | 87 | 0.61(0.23) | 37 | 0.54(0.16) | 0.07 | 0.12 |
| gamma-Glutamyl transferase (IU/L) | 87 | 40.07(50.25) | 37 | 19.30(11.53) | 21.60 | 0.01 |
| Globulin (mg%) | 87 | 3.02(0.50) | 37 | 2.86(0.34) | 0.15 | 0.09 |
| Serum CALCIUM (mg%) | 87 | 9.71(0.38) | 37 | 9.23(0.36) | 0.48 | <0.0001 |
| Creatinine Phosphokinase (IU/L) | 87 | 127.44(90.63) | 37 | 110.43(54.02) | 16.02 | 0.32 |
1. Natural Killer Cells = CD16 + 56+/CD45+
SD = Standard Deviation
Exposure information for Lupus cases in Westgate Subdivision
| 1 | 43 | Present | 14 | Female | 8/21/45 (57) |
| 2 | 26 | Present | 22 | Female | 11/6/54 (48) |
| 3 | 11 | 22 | 11 | Female | 1/4/76 (27) |
| 4 | 30 | Present | 19 | Female | 1/23/54 (49) |
| 5 | 37 | Present | 12 | Female | 7/3053 (49) |
| 6 | 31 | 45 | 14 | Male | 6/7/56 (46) |
| 7 | 33 | 35 | 2 | Female | 8/7/45 (57) |
| 8 | 38 | 43 | 5 | Female | 12/4/39 (63) |
| 9 | 28 | 30 | 2 | Female | 1/21/63 (40) |
| 10 | 62 | 72 | 10 | Female | 12/20/26 (76) |
| 11 | 18 | 40 | 22 | Female | 4/20/59 (43) |
| 12 | 35 | 49 | 14 | Female | 9/23/51 (51) |
| 13 | 3 | 29 | 26 | Female | 12/12/1972 (29) |
Estimated odds ratios and confidence intervals for autoimmune disorders comparing residents to controls
| Exposed N(%) or mean ± s.d. | Unexposed N(%) or mean ± s.d. | Odds Ratio | 95% Confidence Interval | P-value | |
| Rheumatic Diseases | 33 (39.29) | 16 (12.40) | 10.78 | 4.14, 28.12 | <0.0001 |
| Systemic lupus erythematosus | 13(14.29) | 1 (0.78) | 19.33 | 1.96,190.72 | 0.01 |
| Immune | 9 (11.11) | 1 (0.78) | 26.44 | 2.67,261.50 | 0.005 |
| Anemia | 22 (26.19) | 29 (22.48) | 1.14 | 0.49, 2.65 | 0.76 |
| Numbness in Fingers | 49 (58.33) | 34 (26.36) | 3.96 | 1.93, 8.15 | <0.0002 |
| Mouth Sores | 18 (21.43) | 6 (4.65) | 5.66 | 1.78, 18.03 | 0.03 |
| Rash on the Cheeks | 17 (20.24) | 4 (3.10) | 8.27 | 2.20, 31.13 | 0.002 |
| Rash from Sunlight | 17 (20.24) | 11 (8.53) | 1.44 | 0.50, 4.13 | 0.50 |
| Pain on Deep Breath | 19 (22.62) | 7 (5.43) | 11.04 | 3.68, 33.13 | <0.0001 |
*Odds ratio and confidence intervals are estimated using logistic regression
Controlled for age, gender, race/ethnicity, education and smoking history
Odds ratios and confidence intervals for neurologic and behavioral disorders comparing exposed and unexposed residents
| Exposed N(%) or mean ± s.d. | Unexposed N(%) or mean ± s.d. | Odds Ratio | 95% Confidence Interval | P-value | |
| Dizziness* | 4.40 ± 3.10 | 2.25 ± 1.96 | 4.42 | 2.37, 8.24 | <0.0001 |
| Lightheadedness* | 4.85 ± 3.12 | 2.65 ± 1.81 | 5.02 | 2.69, 9.34 | <0.0001 |
| Loss of balance* | 3.68 ± 3.07 | 2.24 ± 1.73 | 2.83 | 1.53, 5.22 | 0.0009 |
| Extreme fatigue* | 6.97 ± 3.69 | 3.12 ± 2.40 | 11.50 | 5.94, 22.28 | <0.0001 |
| Somnolence* | 5.08 ± 3.76 | 2.11 ± 1.86 | 4.99 | 2.66, 9.36 | <0.0001 |
| Can't fall asleep* | 4.79 ± 3.79 | 2.89 ± 2.50 | 1.94 | 1.06, 3.54 | 0.03 |
| Wake up frequently* | 5.12 ± 3.79 | 2.91 ± 2.55 | 3.98 | 2.16, 7.36 | >0.0001 |
| Sleep soundly for only a few hours* | 4.83 ± 3.59 | 2.81 ± 2.51 | 4.00 | 2.16, 7.40 | >0.0001 |
| Lack of concentration* | 5.70 ± 3.73 | 3.76 ± 2.66 | 2.67 | 1.47, 4.84 | 0.001 |
| Recent memory loss* | 5.22 ± 3.82 | 3.76 ± 2.66 | 2.87 | 1.58, 5.23 | 0.0006 |
| Decreased libido* | 4.36 ± 4.00 | 2.92 ± 2.35 | 3.00 | 1.60, 5.59 | 0.0006 |
| When driving in familiar areas, do you ever get lost or go the wrong way * | 2.67 ± 2.73 | 1.55 ± 1.33 | 3.05 | 1.54, 6.08 | 0.002 |
* Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history
Odds ratios and confidence intervals for cardiovascular disorders between exposed and unexposed residents.
| Exposed N(%) or mean ± s.d. | Unexposed N(%) or mean ± s.d. | Odds Ratio | 95% Confidence Interval | P-value | |
| Heart Disease* | 5 (6.17) | 4 (3.10) | 1.80 | 0.33, 9.66 | 0.50 |
| Acute Myocardial Infarction * | 3 (3.57) | 3 (2.33) | 2.11 | 0.17, 25.93 | 0.56 |
| Stroke* | 5 (5.95) | 1 (0.78) | 15.41 | 0.78, 304.68 | 0.07 |
| Angina* | 15 (17.86) | 5 (3.88) | 5.72 | 1.68, 19.43 | 0.005 |
| Rhythm | 10 (12.35) | 18 (13.95) | 0.61 | 0.22, 1.68 | 0.34 |
| Chest tightness** | 3.74 ± 2.82 | 1.92 ± 1.54 | 5.97 | 3.13, 11.40 | >0.0001 |
| Palpitations** | 3.03 ± 2.69 | 2.35 ± 1.98 | 1.64 | 0.87, 3.07 | 0.12 |
| Pain in Chest** | 3.42 ± 2.88 | 1.73 ± 1.65 | 4.24 | 2.21, 8.14 | <0.0001 |
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history
Odds ratios and confidence intervals for respiratory disorders between exposed and unexposed residents
| Exposed | Unexposed | 95% | |||
| N(%) or mean ± s.d. | N(%) or mean ± s.d. | Odds Ratio | Confidence Interval | P-value | |
| Pneumonia* | 11(13.58) | 18(13.95) | 1.19 | 0.45, 3.15 | 0.72 |
| Pleurisy* | 5 (6.33) | 4 (3.10) | 1.48 | 0.29, 7.61 | 0.64 |
| Chronic bronchitis* | 16 (19.75) | 3 (2.33) | 17.4 | 4.06, 74.35 | 0.0001 |
| Dry cough** | 4.64 ± 3.21 | 2.36 ± 1.74 | 5.06 | 2.67, 9.60 | <0.0001 |
| Cough with mucous** | 4.73 ± 3.51 | 2.79 ± 1.75 | 2.6 | 1.43, 4.73 | 0.002 |
| Cough with Blood** | 2.30 ± 2.55 | 1.11 ± 0.45 | 11.8 | 4.33, 32.03 | <0.0001 |
| Asthma Diagnosed by MD* | 11 (13.41) | 17 (13.18) | 2.13 | 0.78, 5.82 | 0.14 |
| Rhinitis* | 24 (29.63) | 21 (16.28) | 3.45 | 1.49, 8.01 | 0.004 |
| Sinusitis range** | 4.57 ± 3.71 | 2.50 ± 1.91 | 2.62 | 1.43, 4.79 | 0.002 |
| Short of Breath at Rest* | 23 (27.38) | 4 (3.10) | 11.3 | 3.11, 40.98 | 0.0002 |
| Short of Breath on Walking* | 40 (48.19) | 6 (4.65) | 34.3 | 10.52, 112.09 | <0.0001 |
| Short of Breath Climbing Stairs* | 52 (62.65) | 34 (26.36) | 6.17 | 2.81, 13.56 | <0.0001 |
| Wheezing* | 24 (28.57) | 7 (5.43) | 19.2 | 5.59, 65.98 | <0.0001 |
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history
Odds ratios and confidence intervals for other disorders between exposed and unexposed residents
| Exposed N(%) or mean ± s.d. | Unexposed N(%) or mean ± s.d. | Odds Ratio | Confidence Interval | P-value | |
| Diabetes* | 10 (12.35) | 6 (4.65) | 3.26 | 0.96, 11.10 | 0.06 |
| Reduced sense of smell** | 3.80 ± 3.53 | 2.12 ± 2.23 | 3.77 | 1.96, 7.25 | <0.0001 |
| Nausea** | 4.54 ± 3.20 | 2.23 ± 1.51 | 4.82 | 2.58, 8.99 | <0.0001 |
| Loss of appetite** | 3.80 ± 2.70 | 2.13 ± 1.49 | 3.44 | 1.86, 6.37 | <0.0001 |
| Stomach swells or is bloated** | 5.07 ± 3.78 | 2.13 ± 1.80 | 6.76 | 3.46, 13.19 | <0.0001 |
| Constipation** | 4.16 ± 3.36 | 2.68 ± 2.14 | 2.90 | 1.58, 5.35 | 0.0006 |
| Diarrhea** | 3.78 ± 2.89 | 2.55 ± 1.75 | 2.75 | 1.49, 5.06 | 0.001 |
| Poor bladder control** | 3.40 ± 3.59 | 2.34 ± 2.13 | 2.50 | 1.30, 4.82 | 0.006 |
| Hair Loss* | 33 (39.76) | 6 (4.65) | 14.12 | 4.57, 43.65 | <0.0001 |
| Seizures* | 4 (4.76) | 5(3.88) | 0.85 | 0.18, 4.02 | 0.84 |
*Odds ratio and confidence intervals are estimated using logistic regression
** Odds ratio and confidence intervals are estimated using multinomial logistic regression models with generalized estimating equations (GEE); odds ratio interpreted as the odds of exposed being in a higher category compared to unexposed. Respondents were asked to "score each question on a scale of 1 – 11, one representing never and 11 representing always.
Controlled for age, gender, race/ethnicity, education and smoking history